Janux Therapeutics, Inc. (JANX) Earnings
|
Expand Research on JANX
| Next EPS Date | 11/10/26 | EPS Growth Rate | -20.5% |
|---|---|---|---|
| Average EPS % Beat Rate | +14.2% | Revenue Growth Rate | -24.7% |
| Average % Move 1-Wk after EPS | -1.2% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/10/26  |
Q326 | N/A | -$0.47 | N/A | N/A | $7.53M | N/A | N/A | N/A | ||
| 8/6/26 |
Q226 | -$0.35 | -$0.27 | -$0.08 | $10.27M | $17.94M | N/A |  | | Details | |
| 5/7/26 |
Q126 | -$0.39 | -$0.57 | +$0.18 | $3.73M | $4.18M | N/A | | | Details | |
| 2/26/26 |
Q425 | -$0.51 | -$0.62 | +$0.11 | N/A | $142.86K | N/A | | | Details | |
| 11/6/25 |
Q325 | -$0.39 | -$0.62 | +$0.23 | $10M | $2.88M | N/A | | | Details | |
| 8/12/25 |
Q225 | N/A | -$0.46 | N/A | N/A | $272.73K | N/A | N/A | N/A | ||
| 5/9/25 |
Q125 | -$0.38 | -$0.37 | -$0.01 | N/A | $363.64K | N/A | | | Details | |
| 3/7/25 |
Q424 | N/A | -$0.43 | N/A | N/A | $1.15M | N/A | N/A | N/A |
